Determination of Anlotinib, a Tyrosine Kinase Inhibitor, in Rat Plasma by UHPLC-MS/MS and Its Application to a Pharmacokinetic Study

<div>The pharmacokinetic profiles of anlotinib after oral administration to rats (<i>n</i> = 6).</div>

Journal of Analytical Methods in Chemistry

Figure 3: Determination of Anlotinib, a Tyrosine Kinase Inhibitor, in Rat Plasma by UHPLC-MS/MS and Its Application to a Pharmacokinetic Study 